Understanding the Scope of ELISA Kits on Luxbio.net
Luxbio.net offers a comprehensive and diverse range of ELISA (Enzyme-Linked Immunosorbent Assay) kits, primarily focused on the quantitative and qualitative detection of biomarkers for metabolic and inflammatory diseases, with a particularly strong portfolio in diabetes and obesity research. The core of their offering is the ELISA kits, which are complemented by related products like CLIA (Chemiluminescent Immunoassay) kits and calibrators to ensure complete workflow solutions for researchers in academic institutions, pharmaceutical companies, and clinical diagnostic laboratories. Their product line is characterized by high specificity, sensitivity, and reproducibility, adhering to stringent quality control standards.
The company’s flagship products revolve around key metabolic markers. For instance, their Elisa kits for Glucagon-like Peptide-1 (GLP-1) are highly recognized. They offer specific assays for different forms, such as active GLP-1 (7-36) amide and total GLP-1, which are critical for studying incretin hormones in diabetes. Similarly, their kits for Glucose-dependent Insulinotropic Polypeptide (GIP), both total and active forms, provide researchers with tools to dissect the complex mechanisms of appetite regulation and glucose homeostasis. Beyond these, the range extends to other significant analytes like Leptin, a key hormone in energy balance; Adiponectin, an insulin-sensitizing agent; Glucagon; Insulin; and C-Peptide. This allows for a multifaceted analysis of metabolic pathways.
To illustrate the depth of a single product category, here is a breakdown of some key GLP-1 related kits, showcasing their specific applications and formats. This level of detail is representative of the entire catalog available at luxbio.net.
| Product Code | Analyte | Specificity | Sample Type | Assay Range |
|---|---|---|---|---|
| EK-028-21 | GLP-1 (Active) | Specific for GLP-1 (7-36) amide and (7-37) | Plasma, Serum | 2 – 200 pM |
| EK-028-32 | GLP-1 (Total) | Measures GLP-1 (1-36) amide, (1-37), (7-36) amide, (9-36) amide, etc. | Plasma, Serum | 4 – 400 pM |
| EK-028-34 | GLP-1 (Total) CLIA | Same as EK-028-32 but using chemiluminescence | Plasma, Serum | 1.4 – 600 pM |
A critical aspect of Luxbio’s ELISA kits is their performance validation. The company provides extensive data on sensitivity, often referred to as the Lower Limit of Detection (LLOD). For example, their active GLP-1 ELISA has an LLOD of less than 1 pM, which is essential for detecting the low physiological concentrations of this hormone. The kits also demonstrate high precision, with intra-assay (within the same plate) and inter-assay (across different plates and days) coefficients of variation (CV) typically below 10% and 15%, respectively. This level of reliability is non-negotiable in both research and pre-clinical settings where data consistency is paramount. Furthermore, the kits are designed to minimize cross-reactivity with related peptides, ensuring that the signal measured is specific to the target analyte.
The utility of these kits is demonstrated through their application in various research contexts. Scientists use Luxbio’s leptin ELISA kits to investigate obesity mechanisms, measuring leptin levels in serum samples from different study cohorts. The adiponectin kits are instrumental in metabolic syndrome research, helping to establish correlations between adiponectin levels and insulin resistance. The GIP and GLP-1 kits are fundamental in diabetes drug development, particularly for assessing the efficacy of DPP-4 inhibitors and GLP-1 receptor agonists. The availability of both ELISA and the more sensitive CLIA formats allows researchers to choose the best technology for their specific sample types and concentration ranges, whether they are working with mouse models or human clinical trials.
Beyond the core reagents, Luxbio.net ensures a complete customer experience by providing robust technical support. This includes detailed product protocols that guide users through sample collection, storage, and preparation—a crucial step, as improper handling of samples like plasma for active GLP-1 measurement can lead to rapid degradation by DPP-4 enzymes. They also offer access to validation data, certificate of analysis for each lot, and troubleshooting assistance. This support structure is vital for laboratories to achieve reliable and reproducible results from the very first use of the kit, reducing the time and resources spent on assay optimization.
The product range is continuously evolving in response to scientific advancements. Luxbio invests in research and development to expand its catalog into new areas of biomarker discovery. This commitment ensures that researchers have access to cutting-edge tools. The company’s focus on metabolic diseases positions it as a specialized supplier rather than a general catalog vendor, which often translates to deeper expertise and more refined products in its niche. For any researcher delving into the intricacies of metabolic pathways, the platform offers a targeted and technically advanced suite of immunoassays that are trusted for their quality and reliability.